Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Hyperuricemia Risk
Nutrition, Metabolism and Cardiovascular Diseases · 2026
DOI: 10.1016/j.numecd.2026.104623 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026. Verfasst von Shanshan Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolism, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China; Jiangxi Clinical Research…. Hauptthemen laut MEDLINE: Hyperuricemia, Uric Acid, Cholesterol, HDL, Cholesterol. Die Arbeit nennt 39 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
BACKGROUND AND AIMS: The predictive value of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) for hyperuricemia risk remains inadequately explored. This study aims to elucidate the relationship between NHHR and the incidence of hyperuricemia in a cohort of Chinese adults. METHODS: We conducted a prospective, longitudinal analysis using data from the China Health and Retirement Longitudinal Study (CHARLS). The study included 7102 participants free from hyperuricemia at baseline. NHHR was computed as the ratio of non-HDL-C to HDL-C. The primary outcome was new-onset hyperuricemia, defined by serum uric acid (SUA) levels ≥417μmol/L (7mg/dL) in males or ≥357μmol/L (6mg/dL) in females during follow-up. RESULTS: Over a follow-up period of 4 years, 626 participants developed new-onset hyperuricemia. An elevated NHHR was significantly associated with an increased risk of hyperuricemia, with an adjusted-odds ratio (OR) of 1.21 (95% confidence interval [CI]: 1.15-1.27) per 1-unit increase in NHHR. The risk was markedly higher in the highest NHHR quartile compared to the lowest (OR: 2.64, 95% CI: 2.01-3.47). The area under the receiver operating characteristic curve for NHHR in predicting hyperuricemia was 0.61, reflecting superior predictive accuracy compared to other lipid parameters. CONCLUSION: NHHR serves as an independent predictor of new-onset hyperuricemia in Chinese adults, with higher ratios correlating with a significantly increased risk. These results propose NHHR as a potential clinical marker for identifying individuals at elevated risk for hyperuricemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrine and Metabolism, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, China; Jiangxi Clinical Research Center for Endocrine and Metabolic Disease, Nanchang, Jiangxi, China;…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Li, S., Hao, Z., Zheng, P., Xi, Y., Zhang, J., Deng, Y., Li, Y., Hu, Y., Xu, J., & Wang, J. (2026). Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Hyperuricemia Risk. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2026.104623
Vancouver
Li S, Hao Z, Zheng P, Xi Y, Zhang J, Deng Y, et al. Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Hyperuricemia Risk. Nutrition, Metabolism and Cardiovascular Diseases. 2026. doi:10.1016/j.numecd.2026.104623
BibTeX
@article{Li2026,
author = {Li, Shanshan and Hao, Zejin and Zheng, Peng and Xi, Yanhua and Zhang, Junping and Deng, Yuanyuan and Li, Yuxia and Hu, Ying and Xu, Jixiong and Wang, Jiancheng},
title = {Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Hyperuricemia Risk},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
doi = {10.1016/j.numecd.2026.104623}
}
EUVIMED